Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation

Molecular Pharmacology

Volumn 72, Issue 6, 2007, Pages 1586-1592

  Yoo, Jinsang ^a   Lee, Yong J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CASPASE; DNA FRAGMENT; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; SMALL INTERFERING RNA; SURVIVIN; TRANSCRIPTION FACTOR E2F1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN LNCAP; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

APOPTOSIS; ASPIRIN; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 36348999296     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.039610     Document Type: Article

References (40)

1. Altieri DC (2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581-8589.
2. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, et al. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Investig 104:155-162.
3. Bair WB, Hart N, Einspahr J, Liu G, Dong Z, Alberts D, and Bowden GT (2002) Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis. Cancer Epidemiol Biomarkers Prev 11:1645-1652.
4. Bartlett JM, Brawley D, Grigor K, Munro AF, Dunne B, and Edwards J (2005) Type I receptor tyrosine kinases are associated with hormone escape in prostate cancer. J Pathol 205:522-529.
5. Bouralexis S, Findlay DM, Atkins GJ, Labrinidis A, Hay S, and Evdokiou A (2003) Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy. Br J Cancer 89:206-214.
6. Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, and Beckman BS (1998) Differences in susceptibility to tumor necrosis factor-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res 58:4940-4946.
7. Crook NE, Clem RJ, and Miller LK (1993) An apoptosis inhibiting baculovirus gene with a zinc finger like motif. J Virol 67:2168-2174.
8. Curtin JF and Cotter TG (2003) Defects in death-inducing signalling complex formation prevent JNK activation and Fas-mediated apoptosis in DU 145 prostate carcinoma cells. Br J Cancer 89:1950-1957.
9. Dignam JD, Lebovitz RM, and Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res 11:1475-1489.
10. Fulda S, Jeremias I, and Debatin KM (2004) Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells. Oncogene 23:7611-7620.
11. Hadaschik BA, Sowery RD, and Gleave ME (2007) Novel targets and approaches in advanced prostate cancer. Curr Opin Urol 17:182-187.
12. Hosoi Y, Watanabe T, Nakagawa K, Matsumoto Y, Enomoto A, Morita A, Nagawa H, and Suzuki N (2004) Upregulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Int J Oncol 25:461-468.
13. Hosomi Y, Yokose T, Hirose Y, Nakajima R, Nagai K, Nishiwaki Y, and Ochiai A (2000) Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer 30:73-81.
14. Isaacs JT, Furuya Y, and Berges R (1994) The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. Semin Cancer Biol 5:391-400.
15. Jemal A, Siegel R, Ward E, Murray T, Xu J, and Thun MJ (2007) Cancer statistics 2007. CA Cancer J Clin 57:43-66.
16. Jiang Y, Saavedra HI, Holloway MP, Leone G, and Altura RA (2004) Aberrant regulation of survivin by the RB/E2F family of proteins. J Biol Chem 279:40511-40520.
17. Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, and Choi KS (2005a) Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene 24:6877-6889.
18. Kim EH, Kim SU, and Choi KS (2005b) Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene 24:838-849.
19. Kim KM, Song JJ, An JY, Kwon YT, and Lee YJ (2005c) Pretreatment of acetylsalicylic acid promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by down-regulating BCL-2 gene expression. J Biol Chem 280:41047-41056.
20. Kopp E and Ghosh S (1994) Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959.
21. Lee YJ, Lee KH, Kim HR, Jessup JM, Seol DW, Kim TH, Billiar TR, and Song YK (2001) Sodium nitroprusside enhances TRAIL-induced apoptosis via a mitochondria-dependent pathway in human colorectal carcinoma CX-1 cells. Oncogene 20:1476-1485.
22. Li F and Altieri DC (1999) Transcriptional analysis of human survivin gene expression. Biochem J 344:305-311.
23. Li Y, Xie M, Yang J, Yang D, Deng R, Wan Y, and Yan B (2006) The expression of antiapoptotic protein survivin is transcriptionally up-regulated by DEC1 primarily through multiple sp1 binding sites in the proximal promoter. Oncogene 25:3296-3306.
24. Lin CY, Liang YC, and Yung BY (2006) Nucleophosmin/B23 regulates transcriptional activation of E2F-1 via modulating the promoter binding of NF-κB, E2F-1 and pRB. Cell Signal 18:2041-2048.
25. Lu M, Kwan T, Yu C, Chen F, Freedman B, Schafer JM, Lee EJ, Jameson JL, Jordan VC, and Cryns VL (2005) Peroxisome proliferator-activated receptor γ agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest. J Biol Chem 280:6742-6751.
26. Nyormoi O, Mills L, and Bar-Eli M (2003) An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells. Cell Death Differ 10:558-569.
27. Oh KW, Qian T, Brenner DA, and Lemasters JJ (2003) Salicylate enhances necrosis and apoptosis mediated by the mitochondrial permeability transition. Toxicol Sci 73:44-52.
28. Park SY, Billiar TR, and Seol DW (2002) IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis. Biochem Biophys Res Commun 291:233-236.
29. Pisters LL (1999) The challenge of locally advanced prostate cancer. Semin Oncol 26:202-216.
30. Qiao L, Hanif R, Sphicas E, Shiff SJ, and Rigas B (1998) Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem Pharmacol 55:53-64.
31. Retzer-Lidl M, Schmid RM, and Schneider G (2007) Inhibition of CDK4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL-induced apoptosis via downregulation of survivin. Int J Cancer 121:66-75.
32. Salvesen GS and Duckett CS (2002) IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3:401-410.
33. Suzuki Y, Kondo Y, Himeno S, Nemoto K, Akimoto M, and Imura N (2000) Role of antioxidant systems in human androgen-independent prostate cancer cells. Prostate 43:144-149.
34. Thalmann GN, Anezinis PA, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, and Chung LWK (1994) Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54:2577-2581.
35. Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, Yao J, Ajani J, and Xie K (2003) Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 9:6371-6380.
36. Wong BC, Zhu GH, and Lam SK (1999) Aspirin induced apoptosis in gastric cancer cells. Biomed Pharmacother 53:315-318.
37. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, and Chung LWK (1994) Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer 57:406-492.
38. Wu J, Ling X, Pan D, Apontes P, Song L, Liang P, Altieri DC, Beerman T, and Li F (2005) Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity. J Biol Chem 280:9745-9751.
39. Yin MJ, Yamamoto Y, and Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β. Nature 396:77-80.
40. Zannetti A, Del Vecchio S, Carriero MV, Fonti R, Franco P, Botti G, D'Aiuto G, Stoppelli MP, and Salvatore M (2000) Coordinate upregulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma. Cancer Res 60:1546-1551.